Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Drogo K. Montague, MD, is Professor of Surgery at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University and Director of the Center for Genitourinary Reconstruction in the Glickman Urological and Kidney Institute at Cleveland Clinic in Cleveland, Ohio. Dr. Montague is also Associate Director of the Urology Residency Program.
Dr. Montague attended undergraduate and medical school at the University of Michigan, receiving the degree Doctor of Medicine cum laude in 1968. He obtained his residency training in urology at Cleveland Clinic from 1968 to 1973 and has remained there since. He is certified by the American Board of Urology.
Dr. Montague has special interests in prosthetic surgery for both erectile dysfunction and urinary incontinence as well as penile reconstructive surgery for Peyronie's disease and congenital penile curvature.
Dr. Montague is Trustee Emeritus of the American Board of Urology and a former member of its Examination Committee. He is Past President of the Sexual Medicine Society of North America. He was the Chairman of the American Urological Association's Audio Visual Committee and was the Chairman of its Erectile Dysfunction Guidelines Panel. He was former member of the Editorial Board of the Journal of Urology and he is currently on the Editorial Board of the Journal of Sexual Medicine. He is a member of the American Association of Genitourinary Surgeons.
Dr. Montague is the author of 146 articles, 81 book chapters and the editor of four books, including the recently released Textbook of Reconstructive Urologic Surgery, published by Informa Healthcare, London, 2008.
Reconstructive surgery for Peyronie’s Disease, Peyronie's disease, penile prosthesis implantation, artificial urinary sphincter implantation, erectile dysfunction, impotence, male urinary incontinence
Innovations & Patents
Penile corporeal excavation -- surgical procedure to remove scar tissue for penile prosthesis implantation following removal of infected penile prostheses or for erectile dysfunction following ischemic priapism (Montague DK, Angermeier KW: Corporeal excavation: new technique for penile prosthesis implantation in men with severe corporeal fibrosis. Urol 67: 1072-1075, 2006)
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland
Clinic's procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 8/31/2014 the review process regarding Dr. Montague's disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.